Spots Global Cancer Trial Database for A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Official Title: A Multicentre Surveillance Study to Evaluate the Long-term Safety in Participants Who Have Been Previously Treated With 177Lu-IPN01072 in an Ipsen-sponsored Clinical Study

Study ID: NCT05017662

Conditions

Neuroendocrine Tumors

Interventions

Data collection

Study Description

Brief Summary: The purpose of the protocol is to evaluate the long-term safety of medicine 177Lu-satoreotide tetraxetan (also known as 177Lu-IPN01072 or 177Lu-OPS201) for patients who have previously received 177Lu-satoreotide tetraxetan in the clinical study OPS-C-001 / D-FR-01072-001.

Detailed Description: The study qualifies as interventional not because of the use of an investigational product, but because the imposed specific data collection includes assessments/blood collection and on-site visits not necessarily part of routine clinical practice.